Biotech · Private company
OncXerna Theraputics, Inc.
Track this companyFree. Adds OncXerna Theraputics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- BavituximabPhase 2 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
- navicixizumab monotherapyPhase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- navicixizumab+irinotecanPhase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- navicixizumab+paclitaxelPhase 2 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- Pembrolizumab InjectionPhase 2 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid TumorsPHASE2 · UNKNOWN · started Aug 5, 2022ClinicalTrials.gov NCT05453825 · fetched Nov 12, 2026
- An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer PatientsPHASE2 · COMPLETED · started Sep 11, 2019ClinicalTrials.gov NCT04099641 · fetched Nov 12, 2026